What you should know:
– Limbica London-based provider of clinical mental health AI technology, raises $14 million led by Khosla Ventures.
– Financing, which also includes the participation of Gaingels And Illusianwill fuel Limbic’s expansion into the US healthcare market.
Proven success in the UK, expansion to the US
Limbic’s clinical AI platform has already positively impacted over 260,000 patients through the UK National Health Service (NHS) Talking Therapies program. This technology clearly:
– Increased access to mental health services
– Accelerated patient integration
– Reduced waiting times
– Improvement in the quality of care
The newly secured funding will be used to expand the availability of Limbic’s AI solutions to U.S. healthcare providers. The first partnerships with US health systems and payers will be announced in the coming months.
Addressing disparities and improving efficiency
Limbic’s technology has demonstrably improved access to mental health care, particularly among underserved communities. A recent Nature Medicine study found that the use of Limbic within the NHS led to:
– 179% increase in referrals among non-binary individuals
– 39% increase in referrals among Asian patients
– 40% increase in referrals among black patients
Additionally, peer-reviewed research indicates that Limbic’s platform has saved the NHS over 50,000 hours of clinician time.
Beyond clinical settings: supporting patients between sessions
Limbic offers the world’s first generative mental health companion, providing ongoing support to users between therapy sessions. This chatbot interface uses Limbic’s sophisticated AI to guide users through a variety of activities and educational materials, providing on-demand and clinically rigorous mental health support.
